Health ❯ Healthcare

Cardiovascular Diseases

Heart Failure Hypertension Atherosclerotic Cardiovascular Disease Heart Attack Coronary Artery Disease Acute Coronary Syndrome Cholesterol Management Heart Conditions Heart Attacks Treatment Methods

18 ARTICLES

last mo.

Late‑Stage Trial of Wainua Misses Primary Goal in ATTR‑CM Study

Sponsors say widespread use of TTR stabilizers likely obscured benefit and will reanalyse the full dataset for presentation at the ESC Congress in August.

16 ARTICLES

3mo ago

Single Infusion Gene Editing Lowers LDL by Up to 62% in Early Trial

9 ARTICLES

7mo ago

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

3 ARTICLES

9mo ago

Evolocumab Cuts First Cardiovascular Events in High-Risk Adults, NEJM Trial Shows

3 ARTICLES

9mo ago

AHA Trial Signals Higher One-Year Events With Ticagrelor Than Prasugrel in Diabetic Stent Patients

3 ARTICLES

9mo ago

Alirocumab After Heart Transplant Slashes LDL but Doesn’t Slow One-Year Plaque, CAVIAR Trial Finds

4 ARTICLES

11mo ago

Phase 3 Trial Shows Baxdrostat Lowers Blood Pressure by About 10 mmHg in Hard-to-Control Hypertension

5 ARTICLES

last yr.

New Trials Challenge Routine Beta-Blocker Use After Heart Attack, With Possible Harm in Women

6 ARTICLES

last yr.

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

4 ARTICLES

last yr.

Major Trial Finds Post-Heart Attack Beta-Blockers Unnecessary for Most, With Added Risk for Women

3 ARTICLES

last yr.

BMJ Reveals Data Flaws in Pivotal Ticagrelor FDA Approval Studies

3 ARTICLES

last yr.

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

11 ARTICLES

last yr.

Shingles Vaccine Found to Reduce Cardiovascular Risks by Up to 26%

3 ARTICLES

last yr.

Gene Hackman and Betsy Arakawa's Deaths Officially Attributed to Natural Causes

5 ARTICLES

last yr.

NHS to Trial AI Tool for Predicting Disease and Early Death Risk

6 ARTICLES

2y ago

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

3 ARTICLES

2y ago

COVID-19 Vaccinations Linked to Reduced Heart Attack and Stroke Risks

Cardiovascular Diseases

Late‑Stage Trial of Wainua Misses Primary Goal in ATTR‑CM Study

Single Infusion Gene Editing Lowers LDL by Up to 62% in Early Trial

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

Evolocumab Cuts First Cardiovascular Events in High-Risk Adults, NEJM Trial Shows

AHA Trial Signals Higher One-Year Events With Ticagrelor Than Prasugrel in Diabetic Stent Patients

Alirocumab After Heart Transplant Slashes LDL but Doesn’t Slow One-Year Plaque, CAVIAR Trial Finds

AstraZeneca’s Baxdrostat Hits Phase 3 Goal With 24‑Hour Blood‑Pressure Cuts

Amgen Reports Repatha Cuts First-Event Risk in Primary-Prevention Trial

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

Phase 3 Trial Shows Baxdrostat Lowers Blood Pressure by About 10 mmHg in Hard-to-Control Hypertension

Never miss stories about

Cardiovascular Diseases

New Trials Challenge Routine Beta-Blocker Use After Heart Attack, With Possible Harm in Women

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

Major Trial Finds Post-Heart Attack Beta-Blockers Unnecessary for Most, With Added Risk for Women

BMJ Reveals Data Flaws in Pivotal Ticagrelor FDA Approval Studies

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

Shingles Vaccine Found to Reduce Cardiovascular Risks by Up to 26%

Gene Hackman and Betsy Arakawa's Deaths Officially Attributed to Natural Causes

NHS to Trial AI Tool for Predicting Disease and Early Death Risk

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study

COVID-19 Vaccinations Linked to Reduced Heart Attack and Stroke Risks

Never miss stories about

Cardiovascular Diseases